CD274 and non-small cell lung carcinoma: We aimed to investigate the relationship between metabolic parameters based on 18F-FDG PET/CT and the prognosis of programmed cell death protein 1 or its ligand (PD-1/PD-L1) Immune checkpoint inhibitors (ICI) with/without chemotherapy in advanced non-small cell carcinoma (NSCLC).